|
|
||||||||
Correspondence to:
Thomas M. McIntyre, at 4130 Eccles Institute of Human Genetics, 2030 E. 15 N., University of Utah, Salt Lake City, UT 84112-5330., tom.mcintyre{at}hmbg.utah.edu (E-mail)
Unmitigated oxidative stress is deleterious, as epitomized by CCl4 intoxication. In this well-characterized model of free radical-initiated damage, liver metabolism of CCl4 to CCl3. causes lipid peroxidation, F-ring isoprostane formation, and pathologic leukocyte activation. The nature of the mediator that couples oxidation to the hepatotoxic inflammatory response is uncharacterized. We found that oxidatively modified phosphatidylcholines were present in the livers of CCl4-exposed rats and not in livers from control animals, that CCl4 metabolism generated lipids that activated 293 cells stably transfected with the human platelet-activating factor (PAF) receptor, and that this PAF-like activity was formed as rapidly as isoprostane-containing phosphatidylcholine (iPC) during oxidation. iPC and the PAF-like activity also had similar chromatographic properties. The potential for iPC activation of the PAF receptor has been unexplored, but we conclude that iPC themselves did not activate the PAF receptor, as phospholipase A1 hydrolysis completely destroyed iPC, but none of the PAF-like bioactivity. Oxidatively fragmented phospholipids are potent agonists of the PAF receptor, but mass spectrometry characterized PAF as the major inflammatory component coeluting with iPC.
Oxidatively fragmented phospholipids and iPC are markers of free radical generation in CCl4-intoxicated liver, but PAF generation by activated hepatic cells generated the inflammatory agent. Marathe, G. K., K. A. Harrison, L. J. Roberts II, J. D. Morrow, R. C. Murphy, L. W. Tjoelker, S. M. Prescott, G. A. Zimmerman, and T. M. McIntyre. Identification of platelet-activating factor as the inflammatory lipid mediator in CCl4-metabolizing rat liver. J. Lipid Res. 2001. 42: 587;596.
Supplementary key words:
PAF, inflammation, liver, isoprostane, oxidation
Copyright © 2001 by Lipid Research, Inc.
Original Article
Identification of platelet-activating factor as the inflammatory lipid mediator in CCl4-metabolizing rat liver
Gopal K. Marathea,
Kathleen A. Harrisong,
L. Jackson Roberts, IIe,
Jason D. Morrowe,
Robert C. Murphyg,
Larry W. Tjoelkerf,
Stephen M. Prescottb,d,
Guy A. Zimmermanb,c, and
Thomas M. McIntyrea,b,c
a Department of Pathology, University of Utah, Salt Lake City, UT 84112
b Department of Internal Medicine, University of Utah, Salt Lake City, UT 84112
c Eccles Institute of Human Molecular Biology and Genetics, University of Utah, Salt Lake City, UT 84112
d Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112
e Department of Medicine and Department of Pharmacology, Vanderbilt University, Nashville, TN 37232
f ICOS Corporation, Bothell, WA 98021
g Department of Pediatrics, National Jewish Medical and Research Center, Denver, CO 80206
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
G. K. Marathe, C. Johnson, S. D. Billings, M. D. Southall, Y. Pei, D. Spandau, R. C. Murphy, G. A. Zimmerman, T. M. McIntyre, and J. B. Travers Ultraviolet B Radiation Generates Platelet-activating Factor-like Phospholipids underlying Cutaneous Damage J. Biol. Chem., October 21, 2005; 280(42): 35448 - 35457. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y Yang, E M Nemoto, S A K Harvey, V M Subbotin, and C R Gandhi Increased hepatic platelet activating factor (PAF) and PAF receptors in carbon tetrachloride induced liver cirrhosis Gut, June 1, 2004; 53(6): 877 - 883. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |